Ekso Bionics Holdings Inc (FRA:23E2)
€ 0.58 0.012 (2.11%) Market Cap: 12.76 Mil Enterprise Value: 10.89 Mil PE Ratio: 0 PB Ratio: 0.90 GF Score: 59/100

Q1 2020 Ekso Bionics Holdings Inc Earnings Call Transcript

Apr 30, 2020 / 08:30PM GMT
Release Date Price: €3.5 (-1.49%)
Operator

Greetings and welcome to the Ekso Bionics' First Quarter 2020 Financial Results Conference Call. (Operator Instruction] As a reminder, this conference is being recorded.

It's now my pleasure to introduce your host, David Carey. Please go ahead, sir.

David Carey
Lazar Partners Ltd. - MD of IR

Thank you, operator, and thank you all for participating in today's call. Joining me from Ekso Bionics are Jack Peurach, President and Chief Executive Officer; Jack Glenn, Chief Financial Officer; and Bill Shaw, Chief Commercial Officer.

Earlier today, Ekso Bionics released financial results for the quarter ended March 31, 2020. A copy of the press release is available on the company's website.

Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot